These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 8665514

  • 1. Repression of the insulin receptor promoter by the tumor suppressor gene product p53: a possible mechanism for receptor overexpression in breast cancer.
    Webster NJ, Resnik JL, Reichart DB, Strauss B, Haas M, Seely BL.
    Cancer Res; 1996 Jun 15; 56(12):2781-8. PubMed ID: 8665514
    [Abstract] [Full Text] [Related]

  • 2. Estrogen receptor regulates insulin-like growth factor-I receptor gene expression in breast tumor cells: involvement of transcription factor Sp1.
    Maor S, Mayer D, Yarden RI, Lee AV, Sarfstein R, Werner H, Papa MZ.
    J Endocrinol; 2006 Dec 15; 191(3):605-12. PubMed ID: 17170218
    [Abstract] [Full Text] [Related]

  • 3. Caveolin-1 up-regulates IGF-I receptor gene transcription in breast cancer cells via Sp1- and p53-dependent pathways.
    Glait C, Tencer L, Ravid D, Sarfstein R, Liscovitch M, Werner H.
    Exp Cell Res; 2006 Nov 15; 312(19):3899-908. PubMed ID: 17014845
    [Abstract] [Full Text] [Related]

  • 4. Functional and physical interactions between BRCA1 and p53 in transcriptional regulation of the IGF-IR gene.
    Abramovitch S, Werner H.
    Horm Metab Res; 2003 Nov 15; 35(11-12):758-62. PubMed ID: 14710355
    [Abstract] [Full Text] [Related]

  • 5. The WT1 Wilms' tumor suppressor gene product interacts with estrogen receptor-alpha and regulates IGF-I receptor gene transcription in breast cancer cells.
    Reizner N, Maor S, Sarfstein R, Abramovitch S, Welshons WV, Curran EM, Lee AV, Werner H.
    J Mol Endocrinol; 2005 Aug 15; 35(1):135-44. PubMed ID: 16087727
    [Abstract] [Full Text] [Related]

  • 6. Insulin and insulin-like growth factor-I (IGF-I) receptor overexpression in breast cancers leads to insulin/IGF-I hybrid receptor overexpression: evidence for a second mechanism of IGF-I signaling.
    Pandini G, Vigneri R, Costantino A, Frasca F, Ippolito A, Fujita-Yamaguchi Y, Siddle K, Goldfine ID, Belfiore A.
    Clin Cancer Res; 1999 Jul 15; 5(7):1935-44. PubMed ID: 10430101
    [Abstract] [Full Text] [Related]

  • 7. Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival.
    Law JH, Habibi G, Hu K, Masoudi H, Wang MY, Stratford AL, Park E, Gee JM, Finlay P, Jones HE, Nicholson RI, Carboni J, Gottardis M, Pollak M, Dunn SE.
    Cancer Res; 2008 Dec 15; 68(24):10238-46. PubMed ID: 19074892
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Down-regulation of type I insulin-like growth factor receptor increases sensitivity of breast cancer cells to insulin.
    Zhang H, Pelzer AM, Kiang DT, Yee D.
    Cancer Res; 2007 Jan 01; 67(1):391-7. PubMed ID: 17210722
    [Abstract] [Full Text] [Related]

  • 11. BRCA1 suppresses insulin-like growth factor-I receptor promoter activity: potential interaction between BRCA1 and Sp1.
    Maor SB, Abramovitch S, Erdos MR, Brody LC, Werner H.
    Mol Genet Metab; 2000 Feb 01; 69(2):130-6. PubMed ID: 10720440
    [Abstract] [Full Text] [Related]

  • 12. A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo.
    Burtrum D, Zhu Z, Lu D, Anderson DM, Prewett M, Pereira DS, Bassi R, Abdullah R, Hooper AT, Koo H, Jimenez X, Johnson D, Apblett R, Kussie P, Bohlen P, Witte L, Hicklin DJ, Ludwig DL.
    Cancer Res; 2003 Dec 15; 63(24):8912-21. PubMed ID: 14695208
    [Abstract] [Full Text] [Related]

  • 13. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.
    Liang Y, Wu J, Stancel GM, Hyder SM.
    J Steroid Biochem Mol Biol; 2005 Feb 15; 93(2-5):173-82. PubMed ID: 15860260
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antitumor effects of an adenovirus expressing antisense insulin-like growth factor I receptor on human lung cancer cell lines.
    Lee CT, Wu S, Gabrilovich D, Chen H, Nadaf-Rahrov S, Ciernik IF, Carbone DP.
    Cancer Res; 1996 Jul 01; 56(13):3038-41. PubMed ID: 8674059
    [Abstract] [Full Text] [Related]

  • 18. The SV40 large T antigen-p53 complexes bind and activate the insulin-like growth factor-I promoter stimulating cell growth.
    Bocchetta M, Eliasz S, De Marco MA, Rudzinski J, Zhang L, Carbone M.
    Cancer Res; 2008 Feb 15; 68(4):1022-9. PubMed ID: 18281476
    [Abstract] [Full Text] [Related]

  • 19. Transcriptional regulation of insulin receptor gene promoter in rat hepatocytes.
    Fukuda H, Noguchi T, Iritani N.
    Biochem Biophys Res Commun; 2001 Feb 09; 280(5):1274-8. PubMed ID: 11162666
    [Abstract] [Full Text] [Related]

  • 20. Central role of p53 on regulation of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) expression in mammary carcinoma.
    Pal S, Datta K, Mukhopadhyay D.
    Cancer Res; 2001 Sep 15; 61(18):6952-7. PubMed ID: 11559575
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.